Mazdutide Benefits

Clinical Trials GLP-1 / Weight Loss

Founder & Lead Researcher

Reviewed by Peptide Nerds Editorial · Updated April 2026

Not medical advice. This content is for educational purposes only. Consult a healthcare provider before starting any peptide protocol. Full disclaimer.

How Mazdutide works

Dual GLP-1 and glucagon receptor agonism for appetite suppression and increased energy expenditure.

Reported benefits

Based on available research data, Mazdutide has been associated with the following benefits:

Significant weight loss in Phase 3 trials
Improved metabolic markers

Important context

Benefits reported in clinical trials represent average outcomes across study populations. Individual results vary based on genetics, dosage, duration, and lifestyle factors.

Mazdutide overview Dosage protocol

Related peptides

Survodutide — Up to 19% weight loss in Phase 2 Retatrutide — Phase 3 (TRIUMPH-4): 28.7% average body weight loss at 68 weeks (26.6% placebo-adjusted) — approximately 71.2 lbs at the 12 mg dose (Eli Lilly topline results, December 2025; peer-reviewed publication pending)

Free Peptide Weight Loss Guide

Semaglutide vs. tirzepatide vs. retatrutide. Dosing protocols, side effects, gray market sourcing, and what the clinical trials found.